BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £1, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
Irish Statutory Instruments |
||
|
You are here: BAILII >> Databases >> Irish Statutory Instruments >> Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 3) Regulations S.I. No. 84/2022 URL: http://www.bailii.org/ie/legis/num_reg/2022/0084.html |
||
[New search] [Help]
Notice of the making of this Statutory Instrument was published in | ||
“Iris Oifigiúil” of 1st March, 2022. | ||
I, STEPHEN DONNELLY, in exercise of the powers conferred on me by section 32 (as amended by section 16 of the Irish Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995 (No. 29 of 1995), hereby make the following regulations: | ||
1. (1) These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2022. | ||
(2) The collective citation “the Medicinal Products (Prescription and Control of Supply) Regulations 2003 to 2022” includes these Regulations. | ||
2. In these Regulations— | ||
“Principal Regulations” means the Medicinal Products (Prescription and Control of Supply) Regulations 2003 ( S.I. No. 540 of 2003 ); | ||
“Regulations of 2022” means the Medicinal Products (Prescription and Control of Supply (Amendment) (No. 2) Regulations 2022 ( S.I. No. 57 of 2022 ). | ||
3. The Eighth Schedule (as amended by Regulation 3 of the Regulations of 2022) to the Principal Regulations is amended, in column 5 of the entry for “Comirnaty concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified)”, by substituting “12 years of age” for “16 years of age”. | ||
4. The Twelfth Schedule (as amended by Regulation 4 of the Regulations of 2022) to the Principal Regulations is amended, in column 5 of the entry for “Comirnaty concentrate for dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified)”, by substituting “12 years of age” for “16 years of age”. | ||
| ||
GIVEN under my Official Seal, | ||
24 February, 2022. | ||
STEPHEN DONNELLY, | ||
Minister for Health. | ||
EXPLANATORY NOTE | ||
(This note is not part of the Instrument and does not purport to be a legal interpretation.) | ||
These Regulations amend the Medicinal Products (Prescription and Control of Supply) Regulations 2003. | ||
The purpose of these Regulations is to allow for booster doses of the Comirnaty Covid-19 vaccine to be administered to persons between 12 and 15 years of age. | ||
These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2022. |
